superoxide dismutase mimetic (GSK)

N/A

Report date: 2025/03/20 15:15:42
NME

Base Information

Drug Namesuperoxide dismutase mimetic (GSK)
Drug Alias NameSOD mimetic (GlaxoSmithKline)catalyse mimetic (GSK)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSuperoxide dismutase stimulants
TargetsSuperoxide dismutase
Therapy Area/IndicationsReperfusion InjuryAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsReperfusion InjuryAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A